Interindividual variations in drug disposition. Clinical implications and methods of investigation.

Clinical pharmacokinetics ·Vol. 8 ·No. 5 ·1983-00-00 ·Pages 371-7

Breimer DD

Abstract

暂无摘要

MeSH Terms

Animals Antipyrine/metabolism Humans Individuality Metabolic Clearance Rate Oxidation-Reduction Pharmaceutical Preparations/metabolism Rats

Chemicals

Pharmaceutical Preparations Antipyrine

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Breimer D D

References (28)

28 references, click to expand

The antipyrine test in clinical pharmacology: conceptions and misconceptions.
Clin Pharmacol Ther. 1979 Sep;26(3):275-86 PMID: 111889
Assessment of methods to identify sources of interindividual pharmacokinetic variations.
Clin Pharmacokinet. 1983 Sep-Oct;8(5):378-409 PMID: 6194927
Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity.
J Pharmacol Exp Ther. 1982 Jan;220(1):120-6 PMID: 7053408
Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
Drug Metab Dispos. 1981 Nov-Dec;9(6):541-4 PMID: 6120813
3-Hydroxymethyl antipyrine excretion in urine after an oral dose of antipyrine. A reconsideration of previously published data and synthesis of a pure reference substance.
Pharmacology. 1982;24(3):181-4 PMID: 7071130
Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.
Br J Clin Pharmacol. 1981 Dec;12(6):771-7 PMID: 7340879
Genetic variation in rates of antipyrine metabolite formation: a study in uninduced twins.
Proc Natl Acad Sci U S A. 1981 Aug;78(8):5193-6 PMID: 6946467
Polymorphisms of oxidation at carbon centers of drugs and their clinical significance.
Drug Metab Rev. 1979;9(2):301-17 PMID: 158499
Ethnic differences in drug metabolism.
Clin Pharmacokinet. 1982 Sep-Oct;7(5):373-400 PMID: 6754206
E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.
Clin Pharmacol Ther. 1981 Aug;30(2):189-93 PMID: 7249504
Defective oxidation of drugs: pharmacokinetic and therapeutic implications.
Clin Pharmacokinet. 1982 Jan-Feb;7(1):1-22 PMID: 7042170
Individual differences in the disposition of drugs metabolised in the body.
Clin Pharmacokinet. 1978 Mar-Apr;3(2):155-75 PMID: 346288
Environmental effects on antipyrine half-life in man.
Clin Pharmacol Ther. 1977 Nov;22(5 Pt 2):799-808 PMID: 913037
Environmental factors affecting antipyrine metabolism in London factory and office workers.
Br J Clin Pharmacol. 1979 Mar;7(3):237-43 PMID: 427001
Differential induction of antipyrine metabolism by rifampicin.
Eur J Clin Pharmacol. 1981;21(2):155-60 PMID: 7341283
Intraindividual variation in drug disposition.
Clin Pharmacol Ther. 1979 Oct;26(4):407-19 PMID: 314881
Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man.
Pharmacology. 1979;18(4):210-23 PMID: 461498
Family study of antipyrine clearance.
Br Med J (Clin Res Ed). 1982 Jan 16;284(6310):150-2 PMID: 6799075
Interindividual differences in drug oxidation: clinical importance.
Drug Metab Dispos. 1973 Jan-Feb;1(1):469-82 PMID: 4149420
Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.
J Pharm Sci. 1979 Nov;68(11):1358-66 PMID: 41932
A case of deficiency of N-hydroxylation of amobarbital.
Clin Pharmacol Ther. 1977 May;21(5):530-5 PMID: 558078
Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
Eur J Clin Pharmacol. 1982;21(5):433-41 PMID: 7075648
Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation.
Pharmacology. 1981;22(6):349-58 PMID: 7267701
Factors affecting antipyrine metabolism in West African villagers.
Clin Pharmacol Ther. 1976 Sep;20(3):369-76 PMID: 954356
Pharmacokinetics of simultaneously administered hexobarbital and heptabarbital in rats: an alternative approach to metabolic correlation studies.
J Pharmacol Exp Ther. 1983 Jun;225(3):747-51 PMID: 6134816
Multiplicity of mammalian microsomal cytochromes P-45.
Pharmacol Rev. 1979 Dec;31(4):277-95 PMID: 399809
Genetic and environmental factors affecting drug disposition in man.
Clin Pharmacol Ther. 1977 Nov;22(5 Pt 2):659-79 PMID: 334437
Antipyrine metabolism in the rat by three hepatic monooxygenases.
Life Sci. 1980 Jun 9;26(23):1977-83 PMID: 7401910

Article Info

Journal

Clinical pharmacokinetics

Abbr.

Clin Pharmacokinet

ISSN

0312-5963

DOI

10.2165/00003088-198308050-00001

Published

1983-00-00

Pages

371-7

Language

English

Region

Switzerland

NLM ID

7606849

Subset

External Links

PubMed source DOI: 10.2165/00003088-198308050-00001 View journal details

Analysis Services

Interindividual variations in drug disposition. Clinical implications and methods of investigation.

Contact

WeChat Official Account